ELICIO THERAPEUTICS INC (ELTX:NASDAQ)
$2.8 -0.11 (-3.7801%)
Analysed ELICIO THERAPEUTICS INC (ELTX:NASDAQ) News Sources
ELTX Stock Heads For Worst Day Ever — Elicio Therapeutics' Pancreatic Cancer Data Disappoints
15-06-2026
stocktwits.com
Sector Update: Healthcare Stocks Softer Late Afternoon
15-06-2026
yahoo.com
Stocks Settle Sharply Higher as US-Iran Peace Deal Spurs Optimism
15-06-2026
barchart.com
This Monthly Dividend Powerhouse Is Trading at a Bargain-Bin Valuation
16-06-2026
barchart.com
Elicio Therapeutics Reports Multiple Complete Responses After ELI-002 7P Treatment and Subsequent Therapy with Checkpoint Inhibition in Metastatic mKRAS Pancreatic Cancer
17-06-2026
yahoo.com
Elicio Therapeutics Added to Russell 2000® and Russell 3000® Indexes
29-06-2026
yahoo.com
Elicio Therapeutics Announces Pricing of $15 Million Registered Direct Offering
02-07-2026
yahoo.com
Another Blow For ELTX? Elicio Raises Fresh Capital Weeks After Trial Disappointment
02-07-2026
stocktwits.com
Wall Street Set to Open Higher in Thursday Trading; US Adds Only 57,000 Jobs in June
02-07-2026
yahoo.com
Elicio Therapeutics Announces Closing of $15 Million Registered Direct Offering
06-07-2026
yahoo.com
What is the current price of ELICIO THERAPEUTICS INC (ELTX:NASDAQ)?
The current price of ELICIO THERAPEUTICS INC (ELTX:NASDAQ) is $2.8.
ELICIO THERAPEUTICS INC (ELTX:NASDAQ) absolute price change since previous trading day?
The absolute price change of ELICIO THERAPEUTICS INC (ELTX:NASDAQ) since the previous trading day is $-0.11.
ELICIO THERAPEUTICS INC (ELTX:NASDAQ) percentage price change since previous trading day?
The percentage price change of ELICIO THERAPEUTICS INC (ELTX:NASDAQ) since the previous trading day is -3.7801%.
What is the most recent average sentiment score for ELICIO THERAPEUTICS INC (ELTX:NASDAQ)?
The most recent average sentiment score for ELICIO THERAPEUTICS INC (ELTX:NASDAQ) is 51 out of 100.
What is the most recent average sentiment for ELICIO THERAPEUTICS INC (ELTX:NASDAQ)?
The most recent sentiment for ELICIO THERAPEUTICS INC (ELTX:NASDAQ) is .
SEC-8K** Filing Available For ELICIO THERAPEUTICS INC (ELTX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.